Aurora Cannabis Stock Forecast, Price & News

-0.80 (-8.98 %)
(As of 04/12/2021 12:57 PM ET)
Today's Range
Now: $8.11
50-Day Range
MA: $10.10
52-Week Range
Now: $8.11
Volume345,391 shs
Average Volume21.86 million shs
Market Capitalization$1.61 billion
P/E RatioN/A
Dividend YieldN/A
Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Aurora Cannabis logo

Industry, Sector and Symbol

Industry Medicinals & botanicals
Year FoundedN/A



Sales & Book Value

Annual Sales$207.89 million
Book Value$13.73 per share


Net Income$-2,468,190,000.00
Net Margins-1,238.94%


Market Cap$1.61 billion
Next Earnings Date5/13/2021 (Estimated)


Aurora Cannabis (NYSE:ACB) Stock Price Down 6.2%
April 12, 2021 |  americanbankingnews.com
Aurora Cannabis (NYSE:ACB) Trading 5.1% Higher
April 9, 2021 |  americanbankingnews.com
CIBC Lowers Aurora Cannabis (NYSE:ACB) Price Target to $15.00
April 5, 2021 |  americanbankingnews.com
High Tide Opens Two New Stores in Underserviced Calgary Neighbourhoods
March 25, 2021 |  markets.businessinsider.com
Aurora Cannabis: The Dilution Nightmare Lives On
March 18, 2021 |  seekingalpha.com
See More Headlines


Overall MarketRank

1.47 out of 5 stars

Medical Sector

830th out of 2,011 stocks

Medicinals & Botanicals Industry

5th out of 33 stocks

Analyst Opinion: 3.8Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
-0.80 (-8.98 %)
(As of 04/12/2021 12:57 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ACB News and Ratings via Email

Sign-up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Aurora Cannabis (NYSE:ACB) Frequently Asked Questions

Is Aurora Cannabis a buy right now?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last twelve months. There are currently 6 sell ratings and 9 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Aurora Cannabis stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ACB, but not buy additional shares or sell existing shares.
View analyst ratings for Aurora Cannabis
or view top-rated stocks.

What stocks does MarketBeat like better than Aurora Cannabis?

Wall Street analysts have given Aurora Cannabis a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Aurora Cannabis wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Aurora Cannabis?

Aurora Cannabis saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 26,690,000 shares, an increase of 31.9% from the February 28th total of 20,230,000 shares. Based on an average daily trading volume, of 23,200,000 shares, the days-to-cover ratio is presently 1.2 days. Currently, 13.6% of the company's shares are sold short.
View Aurora Cannabis' Short Interest

When is Aurora Cannabis' next earnings date?

Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Thursday, May 13th 2021.
View our earnings forecast for Aurora Cannabis

How were Aurora Cannabis' earnings last quarter?

Aurora Cannabis Inc. (NYSE:ACB) announced its quarterly earnings data on Thursday, February, 11th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.19) by $0.09. The firm had revenue of $51.93 million for the quarter, compared to analyst estimates of $54.66 million. Aurora Cannabis had a negative trailing twelve-month return on equity of 16.32% and a negative net margin of 1,238.94%.
View Aurora Cannabis' earnings history

How has Aurora Cannabis' stock been impacted by COVID-19 (Coronavirus)?

Aurora Cannabis' stock was trading at $10.3044 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ACB stock has decreased by 21.2% and is now trading at $8.12.
View which stocks have been most impacted by COVID-19

When did Aurora Cannabis' stock split? How did Aurora Cannabis' stock split work?

Aurora Cannabis's stock reverse split on the morning of Monday, May 11th 2020. The 1-12 reverse split was announced on Friday, May 8th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 8th 2020. An investor that had 100 shares of Aurora Cannabis stock prior to the reverse split would have 8 shares after the split.

What price target have analysts set for ACB?

15 equities research analysts have issued twelve-month price targets for Aurora Cannabis' stock. Their forecasts range from $3.60 to $18.00. On average, they expect Aurora Cannabis' stock price to reach $10.93 in the next year. This suggests a possible upside of 34.6% from the stock's current price.
View analysts' price targets for Aurora Cannabis
or view top-rated stocks among Wall Street analysts.

Who are Aurora Cannabis' key executives?

Aurora Cannabis' management team includes the following people:
  • Mr. Michael Singer, Exec. Chairman (Age 56)
  • Mr. Glen Ibbott, Chief Financial Officer
  • Mr. Allan John Cleiren C.P.A., C.A., ICD.D., Chief Operating Officer
  • Ms. Jillian Swainson, Chief Legal Officer & Corp. Sec.
  • Mr. Miguel Martin, CEO & Director (Age 49)
  • Mr. Darryl Vleeming, Exec. VP of Information Services
  • Dr. Jonathan Page Ph.D., Chief Science Officer (Age 52)
  • Ananth Krishnan, VP of Capital Markets & Investor Relations
  • Michelle Lefler, VP of Communications & PR
  • Mr. Carey Squires, Exec. VP, Corp. Devel. & Strategy

Who are some of Aurora Cannabis' key competitors?

What other stocks do shareholders of Aurora Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include (CGC), Cronos Group (CRON), (APHA), NVIDIA (NVDA), (HEXO), Tilray (TLRY), Alibaba Group (BABA), Advanced Micro Devices (AMD), General Electric (GE) and Micron Technology (MU).

What is Aurora Cannabis' stock symbol?

Aurora Cannabis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACB."

How do I buy shares of Aurora Cannabis?

Shares of ACB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aurora Cannabis' stock price today?

One share of ACB stock can currently be purchased for approximately $8.12.

How much money does Aurora Cannabis make?

Aurora Cannabis has a market capitalization of $1.61 billion and generates $207.89 million in revenue each year. The company earns $-2,468,190,000.00 in net income (profit) each year or ($2.86) on an earnings per share basis.

How many employees does Aurora Cannabis have?

Aurora Cannabis employs 2,731 workers across the globe.

What is Aurora Cannabis' official website?

The official website for Aurora Cannabis is auroramj.com.

Where are Aurora Cannabis' headquarters?

Aurora Cannabis is headquartered at 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6.

How can I contact Aurora Cannabis?

Aurora Cannabis' mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company can be reached via phone at 1-855-279-4652 or via email at [email protected]

This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.